Maplight Therapeutics, Inc. · NASDAQ:MPLT

Foff Erin Pennock sold 3,213 Maplight Therapeutics, Inc. shares (Form 4)

Traded Apr 15 to Apr 16, 2026 · Filed Apr 17, 2026

From Apr 15 to Apr 16, 2026, Foff Erin Pennock (Chief Medical Officer) sold 3,213 Maplight Therapeutics, Inc. shares at an average US$27.03 for US$86,859, leaving 400,777 shares. Filed Apr 17, 2026 (Form 4).

Sold
3,213 shares
Price
US$27.03 average (US$26.84 to US$27.49)
Value
US$86,859
Holding after
400,777 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Voting Common StockSale2,044US$26.84401,946Direct
Apr 16, 2026Voting Common StockSale288US$27.01401,658Direct
Apr 16, 2026Voting Common StockSale881US$27.49400,777Direct

Source

View original at SEC

Related